Table 3.
Single Kidney- SK | Elamipretide (N=10) | Placebo (N=11) | ||
---|---|---|---|---|
| ||||
Baseline | 3 months | baseline | 3 months | |
Total kidney volume (CT), mL | 124.7 ± 50 | 127.8 ± 54 | 115.6 ± 46.7 | 112.5 ± 46.9 |
Cortical volume, mL | 71.6 ± 30.3 | 76 ± 32 | 68.8 ± 30.6 | 71.3 ± 30.6 |
Medullary volume, mL | 53.1 ± 22 | 51.8 ± 23 | 46.8 ± 17.4 | 41.2 ± 17.5 |
Cortical perfusion, mL/min per mL of tissue | 1.99 ± 0.8 | 2.9 ± 1.04* | 2.6 ± 0.9 | 2.4 ± 0.39 |
Medullary perfusion, mL/min per mL of tissue | 0.75 ± 0.37 | 0.95 ± 0.4 | 0.92 ± 0.4 | 0.89 ± 0.2 |
Total renal blood flow, mL/min | 202 ± 129 | 261.7 ± 115* | 234 ± 133 | 234 ± 99 |
Cortical flow, mL/min | 157 ± 99 | 212 ± 93.1* | 189 ± 111 | 194.9 ± 87 |
Medullary flow, mL/min | 44.6 ± 36.9 | 49.7 ± 35 | 45.1 ± 27.7 | 39 ± 15 |
P<0.05 vs. baseline (paired t test and Wilcoxon signed-rank test).